Bryologyx

0 followers

‌

BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies.

Industries

Commercial, Biotechnology

Headquarters

Danville, United States

Employees

1-10

Links

Org chart

Thomas M. Loarie

Co-Founder, CEO & Director

Thomas M. Loarie

Collapse

Reza Ilkhani

CFO

Bruce Jenett

General Counsel

David Crockford

VP, Clinical Development & Logistics

Ephraim Vidal

Director, Pharmaceutical Development

Paola Grandi

Senior Scientist, Immunology

Teams

Advisory Team

9 members

Directors Team

6 members

Leadership Team

5 members

Similar companies

Thermo Fisher Scientific

168 followers

Genentech

150 followers

Gilead Sciences

129 followers

Biogen

115 followers

Regeneron

95 followers

Grainger

80 followers

Vertex Pharmaceuticals

59 followers

Alexion Pharmaceuticals

34 followers

GRAIL

27 followers

Staples

24 followers

Ionis Pharmaceuticals

24 followers

Explore companies